The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Piper Sandler analyst Jessica Tassan maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of $600.00.

The FTC report showed that from 2017 to 2022, the three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds ...

According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

Meanwhile, CVS fired back at ... As its provider services and health insurance portfolio overcame a record cyberattack and growing medical costs, UnitedHealth Group announced £11.7 billion ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs ...

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their ...

Shares of CVS Health, UnitedHealth Group and Cigna, owners of the leading pharmacy-benefit managers, all declined, compounding losses from late last year. Neumora Therapeutics slid by more than ...

UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

What To Know: Shares of health insurance companies are trading ... likely boosting investor confidence in these companies. Notably, CVS, Humana and UnitedHealth sold more than half of the Medicare ...